Programmed death ligand-1 (PD-L1) expression is a major immune-suppressive mechanism that is stimulated by the engagement of the PD-1/PD-L1 axis in non-small cell lung cancer (NSCLC). The gene discussed is CD274; the disease is non-small cell lung carcinoma.